Imagine how you will feel when you emerge from hibernation .....
Printable View
Nice 50,000 trades @.54-5 gone through today, well done , bejuses if we were listed on the NZX and going by the recent history of AFT we would be in for a rerating sometime.
With all of the current C R in N Z going on at present Im betting that PAZ will announce one some time shortly--- when the ducks are quacking----feed them !!
From USX newsletter.
Healthy Future: A Pharmazen Story
Given the journey that global markets have gone through over recent months, it is heartening to see those special securities that have remained strong over this time. PharmaZen has been the most notable of these, smashing $100m market capitalisation to become one of the top performing companies listed on the USX. However this spectacular achievement has not been an overnight success.
Based in Christchurch, PharmaZen Ltd (trading as Waitaki Biosciences) is a biotech company focusing on the development, manufacture and B2B marketing of specialised nutritional ingredients. The company’s products targets, both the human and companion animal dietary supplement industries, with over 90% of product exported to foreign markets.
PAZ’s first trade on the USX was in February 2005, at a price of $0.04, and since then has traded below $0.10 for most of its history. That is, until recently.
In early 2018, USX facilitated for PharmaZen a capital raise of c. $4.1m to provide the funds required to accelerate the completion of several major expansion projects, including:
Installation of the largest batch freeze dryer in Australasia (increasing capacity by 75%)
Deployment of its specialised solvent extraction facility
Commissioning of an additional 1,000 sqm of production facilities
GMP (Good Manufacturing Practice) certification, ensuring approval to manufacture active pharmaceutical ingredients by Medsafe
Licensing and patents for further consumer ready products
High levels of demand for its products saw the company fully utilising its new production capacity, and revenue soared to $12.6m in 2018 from $7.3m the previous year. Additionally, PharmaZen strengthened its management team by bringing in a new COO and CTO, who further drove the future aspirations of the company.
In March this year, just as Covid-19 was dealing blows to global markets, PharmaZen released its 2019 financial report which only served to boost investor confidence further. The company increased its YOY revenue by 38%, and its EBITDA by 98%, demonstrating the continued global appetite for its products and the improving margin as staff had time to get used to the new plant.
Since then, PharmaZen has traded as high as $0.55, more than double its pre-lockdown price and 10x the price of its first trade. This rapid growth has seen the company surpass $100m market capitalisation, to become one of the top performing companies listed on the USX.
The capital raise.
Yes doing in tandem with shifting to NZX would save the issues they had with their last capital raise.[wife and I had to get Craigs to sign a form that we knew what we were doing.Forbar would not do this for their clients.As most shareholders at the time were Dunedin based,it caused big problems].
I would expect an update on this NZX listing in their 7th August half year result announcement,and I would think their future projections will be a lot clearer.[and super exciting]
I noted on my morning walk a few days ago,a lot of equipment for the new [third] extraction plant has arrived.
.
7 August half year result and full year forecast can't come soon enough. Shares under pressure. https://www.usx.co.nz/uploads/paperc...pdf?1590377628
Not long now until 7th August.
In the meantime I see a lot of the third extraction plant's equipment is on site.
Earthworks have also commenced at the corner on Nuttrall Drive. Be interesting seeing what they build there.
Well with not a lot of buying support,and only three weeks until their 7th August announcement I put in an opportunist bid at 35 cents this morning.Woke someone up, who then topped me at 40 cents.Last sale price was 45 cents.Be interesting seeing what the next sale price will be.Even more interesting will be seeing whether the 7th August announcement will see the share price over 60 cents.?...lol.
Looking forward to the update. Remember folks, Rome wasn't built in a day even for fast growing companies like this one. I reckon the most important investment tool with this one is the patience to hold really long term.